Total Funding
55
Total FundingVenture - Series Unknown raised
Growth Score
pts
Heat Score
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
55976
Cydan is an orphan drug accelerator focused on identifying and de-risking compounds with therapeutic and commercial potential.
Chris Adams: Founder & CEOPast Role: Tiburio Therapeutics, Co-Founder & Board Member
Imran Babar: Chief Business OfficerPast Role: Tiburio Therapeutics, Co-Founder & Chief Business Officer
About the Company
Cydan is an orphan drug accelerator that identifies and de-risks compounds with therapeutic and commercial potential. Their rigorous process generates data to support a development path and new company formation. Cydan’s experienced and globally networked team brings strong relationships with academia and patient advocacy, deep expertise in drug
development, and a track record of successful product commercialization.
Women Founded
